Delivery of opioids through an inhalation route

Details for Australian Patent Application No. 2002303833 (hide)

Owner Alexza Pharmaceuticals, Inc.

Inventors Zaffaroni, Alejandro C.; Rabinowitz, Joshua, D.

Agent Davies Collison Cave

Pub. Number AU-B-2002303833

PCT Number PCT/US02/16099

PCT Pub. Number WO2002/094234

Priority 60/294,203 24.05.01 US; 60/317,479 05.09.01 US

Filing date 21 May 2002

Wipo publication date 3 December 2002

Acceptance publication date 29 November 2007

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 31/00 (2006.01)

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/192 (2006.01)

A61K 31/216 (2006.01)

A61K 31/27 (2006.01)

A61K 31/404 (2006.01)

A61K 31/405 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/437 (2006.01)

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/49 (2006.01) - Cinchonan derivatives, e.g. quinine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 60/294,203 24.05.01 US; 60/317,479 05.09.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002303833

15 December 2005 Assignment before Grant

  Alexza Molecular Delivery Corporation The application has been assigned to Alexza Pharmaceuticals, Inc.

29 November 2007 Application Accepted

  Published as AU-B-2002303833

3 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303834-DELIVERY OF COMPOUNDS FOR THE TREATMENT OF PARKINSONS THROUGH AN INHALATION ROUTE

2002303832-P.AERUGINOSA MUCOID EXOPOLYSACCHARIDE SPECIFIC BINDING PEPTIDES